MedPath
HSA Approval

PROZINE-10 SYRUP 10 mg/5 ml

SIN02482P

PROZINE-10 SYRUP 10 mg/5 ml

PROZINE-10 SYRUP 10 mg/5 ml

March 6, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AD02

promethazine

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

PROMETHAZINE HCl

10 mg/5 ml

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROZINE-10 SYRUP 10 mg/5 ml - HSA Approval | MedPath